MEI Pharma Inc.: Diferență între versiuni

Pagină nouă: Pagina dedicata companiei MEI Pharma Inc. listata cu simbolul US.MEIP ==Descriere companie== MEI Pharma, Inc. (https://www.meipharma.com/) is a late-stage pharmaceutical company. The Company is focused on development and commercialization of novel cancer therapies. The Company's portfolio of clinical drug candidates includes Zandelisib (f/k/a ME-401), Voruciclib, ME-344, and Pracinostat. Its Zandelisib is an oral phosphatidylinositol 3-kinase (PI3K) delta inhibitor for the t...